Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Medical Blood Collection Needle Assembly Machines Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Blood Collection Needle Assembly Machines Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. In...
-
Q4 2025 revenues of $112M, +46% vs. Q4 2024 Furoscix® Q4 2025 net sales of $23M, +91% vs. Q4 2024 Afrezza® Q4 2025 net sales of $23M, +25% vs. Q4 2024 2025 full year revenues of $349M, +22% vs....
-
– ZYNRELEF® and APONVIE® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise– Achieved $154.9 Million in 2025 Net Revenue– Issues Full-Year 2026 Net Revenue Guidance of $173 to $183...
-
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Green Petroleum Coke Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" report has been added to ...
-
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Petroleum Coke Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Global Petroleum Coke Market Report 2026 is an...
-
Ghent, Belgium, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Leading US liver transplant center completes its first two implantationsMount Sinai Hospital and University of Pennsylvania also complete multiple...
-
Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Prefilled Syringes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's...
-
- Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company’s ambitions to expand its commercialisation activities and advance its...